[PDF][PDF] Ga-68 DOTATATE PET/CT in neuroendocrine tumors: initial experience
Introduction: Neuroendocrine tumors (NET) are a heterogeneous group of neoplasms,
majority of which express somatostatin (SST) receptors. Recently, with the widespread use …
majority of which express somatostatin (SST) receptors. Recently, with the widespread use …
Management Impact of 68Ga-DOTATATE PET/CT in Neuroendocrine Tumors
Purpose The goal of our retrospective single tertiary academic medical center investigation
was to examine the added diagnostic value and clinical impact of 68 Ga-DOTATATE PET/CT …
was to examine the added diagnostic value and clinical impact of 68 Ga-DOTATATE PET/CT …
The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumors: experience from a national referral center in the United …
E Skoura, S Michopoulou… - Journal of Nuclear …, 2016 - Soc Nuclear Med
68Ga-DOTATATE PET/CT scanning is a widely accepted method for imaging of
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …
Current concepts in 68Ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies
L Bodei, V Ambrosini, K Herrmann… - Journal of Nuclear …, 2017 - Soc Nuclear Med
68Ga-DOTATATE PET/CT provides information on the location of somatostatin receptor–
expressing tumors. Integrating this imaging data effectively in patient care requires the …
expressing tumors. Integrating this imaging data effectively in patient care requires the …
PET imaging for thyroid cancers: current status and future directions
AL Giraudet, D Taïeb - Annales d'endocrinologie, 2017 - Elsevier
Positron emission tomography–computed tomography (PET/CT) combines both functional
and anatomic information and provides in vivo molecular information on biological …
and anatomic information and provides in vivo molecular information on biological …
Molecular imaging of thyroid and parathyroid diseases
P Petranović Ovčariček, L Calderoni… - Expert Review of …, 2024 - Taylor & Francis
Introduction Molecular imaging of thyroid and parathyroid diseases has changed in recent
years due to the introduction of new radiopharmaceuticals and new imaging techniques …
years due to the introduction of new radiopharmaceuticals and new imaging techniques …
Theranostics of Thyroid Cancer
Molecular imaging is pivotal in evaluating and managing patients with different thyroid
cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully …
cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully …
Role of [18F] fluorodeoxyglucose positron emission tomography in follow-up of differentiated thyroid cancer
AS Alzahrani, GE Mohamed, A Al Rifai, A Al-Sugair… - Endocrine Practice, 2006 - Elsevier
Objective To assess the diagnostic utility of [18 F] fluorodeoxyglucose positron emission
tomography (FDG PET) in the follow-up of patients with differentiated thyroid cancer (DTC) …
tomography (FDG PET) in the follow-up of patients with differentiated thyroid cancer (DTC) …
[HTML][HTML] PET/CT in the management of differentiated thyroid cancer
The standard treatment of differentiated thyroid cancer (DTC) consists of surgery followed by
iodine-131 (131 I) administration. Although the majority of DTC has a very good prognosis …
iodine-131 (131 I) administration. Although the majority of DTC has a very good prognosis …
Review of fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the follow-up of medullary and anaplastic thyroid carcinomas
N Khan, N Oriuchi, T Higuchi, K Endo - Cancer Control, 2005 - journals.sagepub.com
Background The goal of posttreatment follow-up for medullary and anaplastic thyroid cancer
(MTC and ATC) is the early diagnosis of recurrence or metastases. However, routine follow …
(MTC and ATC) is the early diagnosis of recurrence or metastases. However, routine follow …